Awakn Life Sciences Corp.
AWKNF · OTC
1/31/2024 | 1/31/2023 | 1/31/2022 | 1/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $407 | $551 | $1,623 | $366 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $21 | $44 | $130 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $68 | $281 | $359 | $111 |
| Total Curr. Assets | $496 | $975 | $2,112 | $477 |
| Property Plant & Equip (Net) | $1 | $2,953 | $3,613 | $349 |
| Goodwill | $0 | $0 | $926 | $0 |
| Intangibles | $46 | $57 | $53 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $409 | $173 | $0 |
| Total NC Assets | $47 | $3,418 | $4,764 | $349 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $543 | $4,394 | $6,876 | $825 |
| Liabilities | – | – | – | – |
| Payables | $1,723 | $1,749 | $1,219 | $197 |
| Short-Term Debt | $0 | $387 | $356 | $14 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $37 | $10 | $0 |
| Other Curr. Liab. | $351 | $327 | $281 | $31 |
| Total Curr. Liab. | $2,074 | $2,463 | $1,856 | $242 |
| LT Debt | $0 | $1,909 | $1,453 | $118 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $71 | $544 | $0 |
| Total NC Liab. | $0 | $1,980 | $1,997 | $118 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1,615 | $1,809 | $132 |
| Total Liabilities | $2,074 | $4,443 | $3,853 | $360 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $22,219 | $20,007 | $16,138 | $1,196 |
| Retained Earnings | -$30,965 | -$25,954 | -$16,811 | -$865 |
| AOCI | -$278 | $6,794 | $4,085 | -$3 |
| Other Equity | $7,493 | $0 | $0 | $0 |
| Total Equity | -$1,530 | $848 | $3,411 | $328 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | -$897 | -$388 | $137 |
| Total Liab. & Tot. Equity | $543 | $4,394 | $6,876 | $825 |
| Net Debt | -$407 | $1,745 | $186 | -$234 |